UrgentRx launches new heart attack drug in portable packets
The company’s initial product line also consists of UrgentRx Headache Relief to Go and UrgentRx Ache & Pain Relief to Go. UrgentRx said that its OTC medications are
Mediar Therapeutics has announced a collaboration and option agreement with Ono Pharmaceutical to develop new treatments for fibro-inflammatory diseases.
The facility is expected to help expand ProMetic’s reach into the lucrative plasma-derived therapeutics industry through in-house plasma-derived proteins manufacture at a commercial scale (150,000 liters of plasma
RemedyMD said ComprehensiveBMT solves key challenges of hematopoietic stem cell transplant (HSCT) research such as reporting data obtained from patients and donors (various disparate sources) after aggregating, linking,
NP-1 contains the FDA-approved drugs amitriptyline and ketamine to relieve pain from various peripheral neuropathies in chemotherapy-induced peripheral neuropathy (CPN). The Community Clinical Oncology Program funded, multi-center, double-blind,
L-DOS47, Helix’s first therapeutic immunoconjugate drug candidate under development based upon its novel DOS47 platform technology, is designed to modify the microenvironmental conditions of cancer cells so that